Skip to main content

[New post] Meissa Vaccines Begins Study of RSV Vaccine Candidate in Seronegative Children

Daniel Webster posted: " REDWOOD CITY, Calif.--(BUSINESS WIRE)--Meissa Vaccines ("Meissa"), a biotechnology company developing vaccines to prevent serious viral respiratory infections, announced today the first seronegative participants have received MV-012-968, Meissa's"

Comments

Popular posts from this blog

[New post] Changes in how cholesterol breaks down in the body may accelerate progression of dementia

[New post] Entertainment: You Season 3 Finally Gets Release Date: See the Bloody Announcement

The biggest controversy surrounding Apple’s new iPad Pro isn’t actually an issue at all